Celon Pharma earns PLN 245 mln on share issue
01:53
Polish pharmaceutical company Celon Pharma alloted 13 million B series shares offered in the IPO to institutional investors and 2 million to retail investors, raising the targeted gross PLN 245 million, the company informed in a statement.
Total demand exceeded PLN 1.5 billion. The offering accounts for some 33 percent of the capital or 25 percent of voting rights.
Share rights will be floated on the Warsaw Stock Exchange around October 14.
Celon Pharma is an integrated pharmaceutical company which conducts advanced research and manufactures modern drugs. The company is also a marketing authorization holder for its products.
